Correlation Between HCA Healthcare and Emergent Biosolutions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCA Healthcare and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCA Healthcare and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCA Healthcare and Emergent Biosolutions, you can compare the effects of market volatilities on HCA Healthcare and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCA Healthcare with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCA Healthcare and Emergent Biosolutions.

Diversification Opportunities for HCA Healthcare and Emergent Biosolutions

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between HCA and Emergent is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding HCA Healthcare and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and HCA Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCA Healthcare are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of HCA Healthcare i.e., HCA Healthcare and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between HCA Healthcare and Emergent Biosolutions

Assuming the 90 days trading horizon HCA Healthcare is expected to generate 1.02 times less return on investment than Emergent Biosolutions. But when comparing it to its historical volatility, HCA Healthcare is 1.06 times less risky than Emergent Biosolutions. It trades about 0.03 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,115  in Emergent Biosolutions on September 13, 2024 and sell it today you would lose (251.00) from holding Emergent Biosolutions or give up 22.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy92.07%
ValuesDaily Returns

HCA Healthcare  vs.  Emergent Biosolutions

 Performance 
       Timeline  
HCA Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HCA Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Emergent Biosolutions 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

HCA Healthcare and Emergent Biosolutions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCA Healthcare and Emergent Biosolutions

The main advantage of trading using opposite HCA Healthcare and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCA Healthcare position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.
The idea behind HCA Healthcare and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation